SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-15-040396
Filing Date
2015-07-01
Accepted
2015-07-01 16:15:20
Documents
2
Group Members
JOSHUA LANDESNELSON OBUSWYNNEFIELD CAPITAL MANAGEMENT, LLCWYNNEFIELD CAPITAL, INC.WYNNEFIELD CAPITAL, INC. PROFIT SHARING PLANWYNNEFIELD PARTNERS SMALL CAP VALUE, L.P.WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v414436_sc13d.htm SC 13D 165351
2 JOINT FILING AGREEMENT v414436_ex99-1.htm EX-99.1 10827
  Complete submission text file 0001144204-15-040396.txt   178073
Mailing Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123
Business Address 450 SEVENTH AVENUE SUITE 509 NEW YORK NY 10123 212-760-0814
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (Filed by) CIK: 0001251565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Subject) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-85226 | Film No.: 15965245
SIC: 2834 Pharmaceutical Preparations